NXGL
Nexgel, Inc.Company with tickers: NXGL, NXGLW
CIK
1468929
CUSIP
65344E107
Shares Outstanding
9,131,055
13F Activity (30d)
17 filings
15 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,650,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | $1,589,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | $1,061,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $2,019,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $1,000 | USD | 2025-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-958,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-927,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |